Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Zachary T. Bloomgarden, MD, Editor of the Journal of Diabetes and a Clinical Professor at the Mount Sinai School of Medicine, provides a critical analysis of the recent…
NEW YORK (Reuters Health) – Eptifibatide and tirofiban are effective alternatives to abciximab given during primary percutaneous intervention for ST-elevation MI, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Bedside ultrasound can reliably diagnose clavicle fractures in children seen in the emergency department, with no more discomfort than radiographs — and without…
NEW YORK (Reuters Health) – On a matched-pair analysis, the results of decompressive surgery followed by radiotherapy for metastatic spinal cord compression were seen to be similar to…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer who have not had a recurrence for 5 years after resection may not yet be free and clear.…
NEW YORK (Reuters Health) – A South African study shows that HIV-infected patients do better when they begin treatment above rather than below 200 cells/µL. The results, reported…
NEW YORK (Reuters Health) – Results of primary percutaneous intervention (PCI) in patients with ST-segment elevation MI are better when the procedure is performed via the radial artery…
NEW YORK (Reuters Health) – According to a new report, primary care patients who may have a drug use disorder can be reliably identified with a single-question screening…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
NEW YORK (Reuters Health) – A course of intravenous antibiotic therapy lasting no more than 3 days for hospitalized infants with urinary tract infections is just as successful…
